Publicaciones en las que colabora con Valentina Calamia (50)

2024

  1. Prognostic model to predict the incidence of radiographic knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 5, pp. 661-668

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  2. An Atlas of the Knee Joint Proteins and Their Role in Osteoarthritis Defined by Literature Mining

    Molecular and Cellular Proteomics, Vol. 22, Núm. 8

2022

  1. Association of the serological status of rheumatoid arthritis patients with two circulating protein biomarkers: A useful tool for precision medicine strategies

    Frontiers in Medicine, Vol. 9

2021

  1. A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: a prospective study using data from the Osteoarthritis Initiative

    Osteoarthritis and Cartilage, Vol. 29, Núm. 8, pp. 1147-1154

  2. Proteomic analysis of synovial fibroblasts and articular chondrocytes co-cultures reveals valuable vip-modulated inflammatory and degradative proteins in osteoarthritis

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  3. Targeted phospholipidomic analysis of synovial fluid as a tool for osteoarthritis deep phenotyping

    Osteoarthritis and Cartilage Open, Vol. 3, Núm. 4

2020

  1. Integrative metabolic pathway analysis reveals novel therapeutic targets in osteoarthritis

    Molecular and Cellular Proteomics, Vol. 19, Núm. 4, pp. 574-588

2019

  1. Analysis of endogenous peptides released from osteoarthritic cartilage unravels novel pathogenic markers

    Molecular and Cellular Proteomics, Vol. 18, Núm. 10, pp. 2018-2028

  2. Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis

    Therapeutic Advances in Chronic Disease, Vol. 10

2018

  1. In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis

    International Immunopharmacology, Vol. 64, pp. 86-100

2017

  1. Multiplexed mass spectrometry monitoring of biomarker candidates for osteoarthritis

    Journal of Proteomics, Vol. 152, pp. 216-225

2016

  1. Identification of factors produced and secreted by mesenchymal stromal cells with the SILAC method

    Methods in Molecular Biology (Humana Press Inc.), pp. 551-565

  2. Secretome analysis of human articular chondrocytes unravels catabolic effects of nicotine on the joint

    Proteomics - Clinical Applications, Vol. 10, Núm. 6, pp. 671-680

2015

  1. Lessons from the proteomic study of osteoarthritis

    Expert Review of Proteomics, Vol. 12, Núm. 4, pp. 433-443

  2. The Spanish biology/disease initiative within the human proteome project: Application to rheumatic diseases

    Journal of Proteomics, Vol. 127, pp. 406-413

2014

  1. A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine

    Scientific Reports, Vol. 4

  2. Quantitative proteomic profiling of human articular cartilage degradation in osteoarthritis

    Journal of Proteome Research, Vol. 13, Núm. 12, pp. 6096-6106

  3. Secretome analysis of human mesenchymal stem cells undergoing chondrogenic differentiation

    Journal of Proteome Research, Vol. 13, Núm. 2, pp. 1045-1054

2013

  1. A new fast method for peptide biomarker discovery in human serum by mass spectrometry

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 9, pp. 52-52